SLI Medical Acceptable Dating: we will ship >= 180 days
Storage Requirements
Requires Refrigeration
Strength
400 mg
Type
Intravenous
UNSPSC Code
51202403
Volume
20 mL
Features
BENLYSTA is a B-lymphocyte stimulator (BLyS)-specific inhibitor indicated for the treatment of: patients aged 5 years and older with active
autoantibody-positive systemic lupus erythematosus (SLE) who are receiving standard therapy
BENLYSTA is a B-lymphocyte stimulator (BLyS)-specific inhibitor indicated for the treatment of: adult patients with active lupus nephritis who are receiving standard therapy.
BENLYSTA (belimumab) for injection is a sterile
preservative-free
lyophilized powder for reconstitution and dilution prior to intravenous infusion provided in single‑dose glass vials with a rubber stopper (not made with natural rubber latex) and a flip‑off seal. Each 20‑mL vial contains 400 mg of belimumab.
Requires Refrigeration